Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating RhDNase and biodistribution of PMN serine proteases in cystic fibrosis sputum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Tours | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED